ProCE Banner Activity

The Good, the Bad, and the Uncertain in the Treatment of Schizophrenia

Slideset Download

Learn the latest about personalized treatment of patients with schizophrenia.

Released: April 22, 2021

Share

Faculty

John M. Kane

John M. Kane, MD

Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York
Co-Director, Institute for Behavioral Science, Feinstein Institutes for Medical Research
Northwell Health
Glen Oaks, New York

Greg W. Mattingly

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Joseph P. McEvoy

Joseph P. McEvoy, MD

Professor
Psychiatry and Health Behavior
Psychiatrist
Augusta University
Augusta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by educational grants from

AbbVie Inc.

Intra Cellular Therapies

Neurocrine Biosciences

Sunovion

Partners

GME

ProCE Banner

Faculty Disclosure

Primary Author

John M. Kane, MD

Professor of Psychiatry and Molecular Medicine
Zucker School of Medicine at Hofstra/Northwell
Hempstead, New York
Co-Director, Institute for Behavioral Science, Feinstein Institutes for Medical Research
Northwell Health
Glen Oaks, New York

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Joseph P. McEvoy, MD

Professor
Psychiatry and Health Behavior
Psychiatrist
Augusta University
Augusta, Georgia